Clinical Trial Update: Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis [Phase 4]

View source ↗

Summary

Clinical trial update for Jinshuibao in chronic kidney disease due to glomerulonephritis (Phase 4) assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Glomerulonephritis

Drugs mentioned

• Jinshuibao

Snippet

Sponsor: Jemincare | Conditions: Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4 | Phase 4 | Status: UNKNOWN